SOPHiA GENETICS (SOPH) Notes Payables (2020)

SOPHiA GENETICS (SOPH) reported Notes Payables of $457000.0 for Q4 2020.

SOPHiA GENETICS (SOPH) Notes Payables (2020) Analysis & Trends

SOPHiA GENETICS (SOPH) has 1 years of Notes Payables data on file, last reported at $457000.0 in Q4 2020.

  • For the quarter ending Q4 2020, Notes Payables changed N/A year-over-year to $457000.0; the trailing twelve-month figure through Dec 2020 stood at $457000.0 (changed N/A YoY), and the FY2020 full-year result was $457000.0, changed N/A from the prior year.
  • Notes Payables was little changed at $457000.0 in Q4 2020.
  • In the past five years, Notes Payables ranged from a high of $457000.0 in Q4 2020 to a low of $457000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.95 Bn 24.64 Bn 662.02 Mn
2 BrightSpring Health Services 14.71 Bn 13.81 Bn 482.22 Mn
3 Healthequity 8.35 Bn 8.08 Bn 256.31 Mn
4 10x Genomics 5.93 Bn 5.39 Bn 106.18 Mn
5 Hinge Health 5.92 Bn 5.61 Bn 154.23 Mn
6 MiniMed 4.49 Bn 4.19 Bn 480.00 Mn
7 Waystar Holding 4.42 Bn 4.36 Bn 216.84 Mn
8 Doximity 3.93 Bn 3.19 Bn 125.97 Mn
9 Privia Health 3.11 Bn 2.69 Bn -
10 SOPHiA GENETICS 380.92 Mn 310.64 Mn 14.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 457,000.00